# Kura Oncology, Inc.: Form 8-K, filed Jan 26, 2024

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: 8-K
- Filed: 2024-01-26
- Accepted by EDGAR: Jan 26, 2024, 16:08 ET
- Period: 2024-01-24
- Accession: 0001193125-24-016715
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000119312524016715/d642740d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000119312524016715/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000119312524016715/d642740d8k.htm

Filed Jan 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-016715. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.